Found: 13
Select item for more details and to access through your institution.
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01000-2
- By:
- Publication type:
- Article
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00922-7
- By:
- Publication type:
- Article
Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 11, p. 2264, doi. 10.3390/jcm10112264
- By:
- Publication type:
- Article
Venetoclax plus hypomethylating agents in DDX41‐mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 171, doi. 10.1111/bjh.19105
- By:
- Publication type:
- Article
Clonal heterogeneity in STAG2m myeloid neoplasms: the Mayo Clinic experience.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 1, p. 211, doi. 10.1007/s00277-022-05016-1
- By:
- Publication type:
- Article
Autoimmune manifestations in STAG2-mutated myeloid neoplasms.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 12, p. 2785, doi. 10.1007/s00277-022-04995-5
- By:
- Publication type:
- Article
Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance.
- Published in:
- American Journal of Clinical Pathology, 2022, v. 158, n. 4, p. 530, doi. 10.1093/ajcp/aqac083
- By:
- Publication type:
- Article
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00818-6
- By:
- Publication type:
- Article
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor